T-1301

· Taivex Therapeutics Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T-1301, covering 2024-11-12 to 2024-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors [Phase 1]